Globus Medical (GMED) Stock
Fundamentals
Source: third-party data provider, as of October 14, 2026
Compare with GMED
Recent news

Reasons to Add Globus Medical Stock to Your Portfolio Now
Reasons to Add Globus Medical Stock to Your Portfolio Now
GMED

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific
Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific
GMED

Here's Why Globus Medical (GMED) is a Strong Value Stock
Here's Why Globus Medical (GMED) is a Strong Value Stock
GMED

3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes
3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes
GMED
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 51.14
- MACD 12/26/9
- -0.69
- EMA 9 of MACD
- -1.06
- MACD histogram
- 0.38
- SMA 50
- $78.95
- Price below SMA 50
- EMA 50
- $77.41
- Price below EMA 50
- SMA 200
- $84.22
- Price below SMA 200
- EMA 200
- $81.75
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of October 13, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $0.94 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Reasons to Add Globus Medical Stock to Your Portfolio Now
Reasons to Add Globus Medical Stock to Your Portfolio Now
GMED

Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific
Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific
GMED

Here's Why Globus Medical (GMED) is a Strong Value Stock
Here's Why Globus Medical (GMED) is a Strong Value Stock
GMED

3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes
3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes
GMED

GMED vs. ITGR: Which Stock Is the Better Value Option?
GMED vs. ITGR: Which Stock Is the Better Value Option?
GMED

What Makes Globus Medical (GMED) a New Strong Buy Stock
What Makes Globus Medical (GMED) a New Strong Buy Stock
GMED

Top Robotics Stocks to Add to Your Portfolio for Impressive Returns
Top Robotics Stocks to Add to Your Portfolio for Impressive Returns
GMED

GMED vs. ITGR: Which Stock Should Value Investors Buy Now?
GMED vs. ITGR: Which Stock Should Value Investors Buy Now?
GMED

Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
GMED

New Strong Buy Stocks for September 11th
New Strong Buy Stocks for September 11th
GMED
News tone: automated (AI) classification of the article's content, not a price prediction.
About Globus Medical
Globus Medical is a leading medical device manufacturer with the goal of improving the quality of life for patients with musculoskeletal disorders. We are inspired by the needs of these patients and by the surgeons and healthcare providers who treat them. Our goal is to provide continuous prolific ideas, products and innovations to improve quality of life. Globus offers implantable devices, biologics, accessories and surgical instruments used for various spinal, orthopedic and neurosurgical procedures.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Keith W. Pfeil | CEO, President & Director | 1979 |
| Mr. David C. Paul | Co-Founder & Executive Chairman | 1967 |
| Mr. Kyle R. Klin | Senior VP & CFO | 1986 |
| Ms. Kelly G. Huller Esq. | Executive VP, General Counsel & Corporate Secretary | 1972 |
| Mr. Brian J. Kearns | Senior Vice President of Business Development & Investor Relations | 1967 |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Source: third-party data provider, as of October 14, 2026
Technical indicators
- RSI 14
- 51.14
- MACD 12/26/9
- -0.69
- EMA 9 of MACD
- -1.06
- MACD histogram
- 0.38
- SMA 50
- $78.95
- Price below SMA 50
- EMA 50
- $77.41
- Price below EMA 50
- SMA 200
- $84.22
- Price below SMA 200
- EMA 200
- $81.75
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of October 13, 2026. Technical data, not a recommendation.
Analyst views
4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $82.00
- Average
- $91.50
- High
- $100.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +1.0 | -19.7 | +14.4 | |||||||||
| 2022 | -9.8 | +5.2 | +4.1 | -13.1 | +0.8 | -12.7 | +1.7 | +0.6 | +1.7 | +10.1 | +10.4 | -1.6 |
| 2023 | +3.2 | -24.3 | -2.1 | +2.2 | -6.8 | +8.2 | +3.7 | -8.3 | -8.4 | -7.8 | -2.3 | +15.8 |
| 2024 | -0.7 | +2.9 | -1.5 | -6.3 | +33.1 | +2.7 | +5.9 | +3.7 | -0.9 | +4.5 | +14.3 | -1.4 |
| 2025 | +13.3 | -13.3 | -7.6 | -2.2 | -16.8 | +0.1 | -12.6 | +16.4 | -4.4 | +2.9 | +48.8 | -2.8 |
| 2026 | +3.9 | +6.4 | -8.1 | +2.8 | -10.4 | -1.0 | +3.7 | -0.1 | -6.9 | +2.6 |



